glutathione levels in cancer patients Cell Death Glutathione-mediated nanomedicines for cancer diagnosis

Seven-week-old athymic nude mice from Charles River Laboratory were inoculated with MIA PaCa-2 tumour cells (ECACC)

, Kim1 expression increased with higher doses of sulfasalazine (Supplemental Figure 6), suggesting a dose-dependent nephrotoxic effect

8 ChenL.HambrightW

because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical

References 1 BersukerK.HendricksJ

Cependant, les tudes scientifiques sur leffet direct du glutathion dans ce domaine sont encore insuffisantes